Suggestions for overcoming the weak points of cardiomyoplasty [9]

Annals of Thoracic Surgery

Volumn 62, Issue 4, 1996, Pages 1245-1247

  Chekanov, V S ^a   Nikolaychik, V V ^a  

^a AURORA SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; APROTININ; GLUE; PROTEINASE INHIBITOR; STEROID;

ANGIOGENESIS; ANIMAL MODEL; CARDIOMYOPLASTY; CARDIOVASCULAR SURGERY; CLINICAL PROTOCOL; DRUG DELIVERY SYSTEM; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 0029826912     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)85173-3     Document Type: Letter

References (6)

1. Magovern GJ Sr Simpson KA Clinical cardiomyoplasty: review of the ten-year United States experience Ann Thorac Surg 61 1996 413 419
2. Magovern GJ Heckler FR Park SB Paced skeletal muscle for dynamic cardiomyoplasty Ann Thorac Surg 45 1988 614 619
3. M489-M494 Chekanov VS Tchekanov GV Rieder MA Is it possible to perform immediate cardiac assist using untrained latissimus dorsi muscle in a work-rest regimen? ASAIO J 41 1995
4. Chekanov VS Krakovsky AA Buslenko NS Cardiomyoplasty: review of early and late results Vasc Surg 28 1994 481 488
5. Chekanov VS Nikolaychik VV Tchekanov GV Rieder MA Cardiomyoplasty: overcoming weak points ASAIO J 42 1996 42
6. M499-M507 Chekanov VS Tchekanov GV Rieder MA Force enhancement of skeletal muscle used for dynamic cardiomyoplasty and as skeletal muscle ventricle ASAIO J 41 1995